Indication
MTD
1 clinical trial
1 product
Product
IBD0333Clinical trial
Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetic (PK) and Preliminary Efficacy of IBD0333 in Patients With Locally Advanced/Metastatic Solid Tumor or Non-Hodgkin LymphomaStatus: Not yet recruiting, Estimated PCD: 2029-12-31